Europe’s largest academic health research partnership created
August 21, 2008Research and Development, Sales and Marketing hc
Five British medical research centres and hospitals have come together to create a new academic health science partnership, the largest …
Drug regulation: still room for improvement
August 15, 2008Research and Development, Sales and Marketing drug safety, medicines act
This year is a bit of a jamboree of health-related anniversaries, with the NHS celebrating 60 years and the Medicines …
Latest news from Datamonitor
August 15, 2008Sales and Marketing digi
Clinical decision support tools, technologies that provide information to aid the diagnosis and treatment of patients, are set to make …
Parexel seals ClinPhone deal
August 15, 2008Research and Development
Parexel has finalised its acquisition of ClinPhone after rivals Quintiles dropped out of the race for the clinical technology firm. …
AstraZeneca signs Singapore cancer research deal
August 15, 2008Research and Development AstraZeneca, Singapore, emerging markets
AstraZeneca has signed a deal to work with Singapore’s National Cancer Centre and National University Hospital to develop new cancer …
Pfizer to close Irish manufacturing site
August 15, 2008Manufacturing and Production
Pfizer is to close its manufacturing site in Cork with the loss of 180 jobs, following a failed 18-month effort …
ABPI attracts new members
August 15, 2008UK industry body the ABPI has swelled its ranks with the addition of three new full members, bringing its total …
Schering-Plough expands in China
August 15, 2008Sales and Marketing
Schering-Plough has expanded its presence in China by taking full control of an existing partnership based in Shanghai.The company has …
Boehringer hit by currencies
August 14, 2008Sales and Marketing
Boehringer Ingelheim has been hit by the strength of the euro, which has hit its revenues and profits in the …
Bayer boosts pre-clinical oncology pipeline
August 8, 2008Research and Development
Bayer Schering Pharma has acquired two potential cancer drugs and a range of oncology compounds from Nycomed in a deal …
Genentech won’t surrender independence without a fight
August 8, 2008Sales and Marketing
Roche has moved to end its 'arm's length' arrangement with Genentech, offering to buy the remaining shares in the company …
NHS ‘Integrated Care’: from buzzword to reality?
August 8, 2008Primary care professionals have urged the government to fulfil its promise of a new commissioner-led health service, and call for …
NICE set to deny access to kidney cancer drugs
August 8, 2008Sales and Marketing
Four treatments for advanced kidney cancer have been rejected by NICE even though they show significant clinical benefits. The Institute's …
Tracleer wins wider EU licence
August 8, 2008Sales and Marketing
Actelion's Tracleer (bosentan) has been approved in Europe to treat patients with mildly symptomatic pulmonary arterial hypertension (PAH). The move …
Actemra close to US approval
August 8, 2008Sales and Marketing
US regulars have recommended Roche's Actemra (tocilizumab) be approved to treat adults with moderate to severe rheumatoid arthritis (RA). The …
Latest news from Datamonitor
August 5, 2008Research and Development, Sales and Marketing
Biovest/Accentia's BiovaxID revives hope for therapeutic cancer vaccines Biovest, a subsidiary of Accentia, has announced positive data from a pivotal …
Currency lifts Wyeth to 5% growth
July 31, 2008Sales and Marketing
Wyeth saw revenues increase 5% in the second quarter of the year to $5.9 billion, contributing to six month sales …
Sanofi boosts vaccines pipeline with Acambis acquisition
July 31, 2008Sales and Marketing
Sanofi-Aventis has snapped up UK biotech Acambis for £276 million, gaining access to an early-stage pipeline of vaccine candidates targeting …
Lilly’s second quarter marred by prasugrel delay
July 31, 2008Sales and Marketing
A delay to a key new product took the shine off Lilly's strong second quarter, which saw sales increase 11% …
Latest content
